Chief Ethics, Risk & Compliance Officer of Novartis since 2018
Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk & Compliance Officer and a member of the Executive Committee. He was previously chief compliance officer at Siemens AG, where he spent 18 years in roles of increasing seniority. He began his career as a lawyer in Germany, specializing in white-collar crime, business law and litigation.
Today, Klaus is transforming ethics, risk and compliance at Novartis in the same way the company is reimagining medicine – by pursuing innovation, using data and digital, and unleashing the creative power of employees to embed ethics into the core of the business.
“Doing what’s right for patients and society is, and must always be, our priority. It’s a journey, and we remain humble in our understanding that this will take time. But we are well on our way.”
Klaus led the launch of a new Code of Ethics in 2020, based on crowdsourced feedback from employees and on behavioral science. He introduced an integrated risk management system that helps senior management prioritize and manage key risks across the company, supported by a new policy and control framework. And he set up a new process to ensure human rights are further integrated into core business practices, especially third-party risk management.
Klaus brings a global reputation as a leader in the field of ethics and compliance. He was the first head of compliance from a company to be invited to address the General Assembly of the United Nations about the fight against corruption. He leads global integrity, compliance, and anti-corruption bodies for business on behalf of the Organization for Economic Co-operation and Development (OECD) and the G20/B20.
As a believer in collaboration, Klaus co-founded and chaired a nonprofit association of compliance heads from major European companies and is on the advisory panel of the Pharmaceutical Supply Chain Initiative to further drive compliance standards at an international level.